Ochre Bio
YC W20 · EF 2019 · Active · RNA medicines for liver diseases
Competitors
| Company | Category | Status | Program |
|---|---|---|---|
| Other | Not stated | EF2025 | |
| Other | Active | YCS18 | |
| AI | Active | YCW20 | |
| Other | Acquired | YCW16 | |
| Other | Active | YCW21 |
Adjacent
| Company | Category | Status | Program |
|---|---|---|---|
| Other | Active | YCW17 | |
| Other | Inactive | YCS18 | |
| AI | Active | YCS25 | |
| Other | Not stated | Plug and Play | |
| AI | Active | YCS20 |
Also from W20
All of W20Programs
| Program | Cohort | Source |
|---|---|---|
| W20 · Winter 2020 | YC Page | |
| 2019 | EF Page |
About Ochre Bio
Ochre Bio is a biotechnology company developing RNA medicines for chronic liver diseases.
- YC batch
- W20 · Winter 2020
- Status, per YC
- Active
- Category
- Other
- Team size
- 50
- Location
- London, England, United Kingdom; Oxford, England, United Kingdom
- Checked
- 1h ago
Ochre Bio: questions
Which YC batch was Ochre Bio in?
Ochre Bio was in Y Combinator's Winter 2020 batch (W20).
Which accelerators did Ochre Bio go through?
Ochre Bio is listed by Y Combinator (W20), Entrepreneur First (2019).
Is Ochre Bio still active?
Y Combinator lists Ochre Bio as active.
Where is Ochre Bio based?
Ochre Bio lists London, England, United Kingdom; Oxford, England, United Kingdom as its location on YC's directory.
Sources: each program's public company list, read twice a week. Not affiliated with Y Combinator or any other program. Logos via logo.dev; trademarks belong to their owners.